Clinical trials for Whooping cough

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Whooping cough. For all clinical trials, go to clinical trials search

This list shows clinical trials for Whooping cough

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Whooping cough
Title Recruitment status Location
Multiboost - MCC plus pertussis booster in adolescents Recruiting United Kingdom
A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants Recruiting United Kingdom
Pertussis and Meningitis C Concomitant Vaccination in Adolescents Recruiting United Kingdom
A phase II, open-label, randomized, multicentre study to evaluate the feasibility of GSK Biologicals’ DTPa-IPV/Hib-MenC-TT vaccine co-administered with Prevenar compared with Pediacel co-administered with Menjugate and Prevenar, when given in healthy infants as a three-dose primary vaccination course at 2, 3 and 4 months of age and to evaluate Menitorix given to these children as a booster dose at 12 months of age - DTPA-IPV=HIB-MENC-TT-001 PRI Not Recruiting United Kingdom
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules Not recruiting United Kingdom
Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children Not recruiting United Kingdom
Montelukast for Persistent Cough in Young People and Adults Not recruiting United Kingdom
A Phase IV, randomised study to evaluate the immune response of UK infants receiving DTaP/Hib/IPV, meningococcal C conjugate and pneumococcal conjugate vaccines, antibody persistence and responses to booster doses in the second year of life. (code: Sched2) - Sched2 Not Recruiting United Kingdom
Hepatitis B Vaccination in Infants Not recruiting United Kingdom
A controlled clinical trial investigating the impact of point of care testing for ‘atypical’ pneumonia, bordetella pertussis and viral pathogens on patient pathways, antimicrobial consumption and cost-efficiency. Not Recruiting United Kingdom

Page last reviewed:

Next review due: